Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 654

1.

Severity of peanut allergy and the unmet gaps in care: a call to action.

Lieberman JA.

Am J Manag Care. 2018 Oct;24(19 Suppl):S412-S418.

2.

Investigation of the HSPG2 Gene in Tardive Dyskinesia - New Data and Meta-Analysis.

Zai CC, Lee FH, Tiwari AK, Lu JY, de Luca V, Maes MS, Herbert D, Shahmirian A, Cheema SY, Zai GC, Atukuri A, Sherman M, Shaikh SA, Tampakeras M, Freeman N, King N, Müller DJ, Greenbaum L, Lerer B, Voineskos AN, Potkin SG, Lieberman JA, Meltzer HY, Remington G, Kennedy JL.

Front Pharmacol. 2018 Sep 18;9:974. doi: 10.3389/fphar.2018.00974. eCollection 2018.

3.

Association study of Disrupted-In-Schizophrenia-1 gene variants and tardive dyskinesia.

Lu JY, Tiwari AK, Zai GC, Rastogi A, Shaikh SA, Müller DJ, Voineskos AN, Potkin SG, Lieberman JA, Meltzer HY, Remington G, Wong AHC, Kennedy JL, Zai CC.

Neurosci Lett. 2018 Nov 1;686:17-22. doi: 10.1016/j.neulet.2018.08.007. Epub 2018 Aug 15.

PMID:
30118782
4.

The past and future of novel, non-dopamine-2 receptor therapeutics for schizophrenia: A critical and comprehensive review.

Girgis RR, Zoghbi AW, Javitt DC, Lieberman JA.

J Psychiatr Res. 2018 Jul 21. pii: S0022-3956(18)30041-4. doi: 10.1016/j.jpsychires.2018.07.006. [Epub ahead of print] Review.

PMID:
30055853
5.

The reliability of motor evoked potentials to predict dorsiflexion injuries during lumbosacral deformity surgery: importance of multiple myotomal monitoring.

Lieberman JA, Lyon R, Jasiukaitis P, Berven SH, Burch S, Feiner J.

Spine J. 2018 Jul 17. pii: S1529-9430(18)31004-0. doi: 10.1016/j.spinee.2018.07.006. [Epub ahead of print]

PMID:
30025994
6.

Psychotic Disorders.

Lieberman JA, First MB.

N Engl J Med. 2018 Jul 19;379(3):270-280. doi: 10.1056/NEJMra1801490. Review. No abstract available.

PMID:
30021088
7.

A predictive model for conversion to psychosis in clinical high-risk patients.

Ciarleglio AJ, Brucato G, Masucci MD, Altschuler R, Colibazzi T, Corcoran CM, Crump FM, Horga G, Lehembre-Shiah E, Leong W, Schobel SA, Wall MM, Yang LH, Lieberman JA, Girgis RR.

Psychol Med. 2018 Jun 28:1-10. doi: 10.1017/S003329171800171X. [Epub ahead of print]

PMID:
29950184
8.

Are there different subtypes of eosinophilic esophagitis?

Lieberman JA.

Ann Allergy Asthma Immunol. 2018 Aug;121(2):143-144. doi: 10.1016/j.anai.2018.05.023. Epub 2018 Jun 1. No abstract available.

PMID:
29860052
9.

Disease modifying effects of antipsychotic drugs in schizophrenia: a clinical and neurobiological perspective.

Lieberman JA.

World Psychiatry. 2018 Jun;17(2):163-165. doi: 10.1002/wps.20543. No abstract available.

10.

A randomized, double-blinded, placebo-controlled study of the use of viscous oral cromolyn sodium for the treatment of eosinophilic esophagitis.

Lieberman JA, Zhang J, Whitworth J, Cavender C.

Ann Allergy Asthma Immunol. 2018 May;120(5):527-531. doi: 10.1016/j.anai.2018.03.006. Epub 2018 Mar 12.

PMID:
29544738
11.

Pathophysiology of drug induced weight and metabolic effects: findings from an RCT in healthy volunteers treated with olanzapine, iloperidone, or placebo.

Ballon JS, Pajvani UB, Mayer LE, Freyberg Z, Freyberg R, Contreras I, Rosenbaum M, Leibel RL, Lieberman JA.

J Psychopharmacol. 2018 May;32(5):533-540. doi: 10.1177/0269881118754708. Epub 2018 Feb 15.

PMID:
29444618
12.

The environment and food allergy.

Lieberman JA, Greenhawt M, Nowak-Wegrzyn A.

Ann Allergy Asthma Immunol. 2018 May;120(5):455-457. doi: 10.1016/j.anai.2018.01.010. Epub 2018 Feb 2. No abstract available.

PMID:
29410214
13.

Understanding fibrosis in eosinophilic esophagitis: Are we there yet?

Armbruster-Lee J, Cavender CP, Lieberman JA, Samarasinghe AE.

J Leukoc Biol. 2018 Jul;104(1):31-40. doi: 10.1002/JLB.5MR1017-395R. Epub 2018 Jan 29. Review.

PMID:
29377264
14.

Identical twins with XLA requiring differing amounts of 20% subcutaneous immunoglobulin secondary to protein-losing enteropathy.

Lan J, Eshun J, Lieberman JA.

J Allergy Clin Immunol Pract. 2018 May - Jun;6(3):1073-1074. doi: 10.1016/j.jaip.2017.11.030. Epub 2018 Jan 12. No abstract available.

PMID:
29339123
15.

Hippocampal dysfunction in the pathophysiology of schizophrenia: a selective review and hypothesis for early detection and intervention.

Lieberman JA, Girgis RR, Brucato G, Moore H, Provenzano F, Kegeles L, Javitt D, Kantrowitz J, Wall MM, Corcoran CM, Schobel SA, Small SA.

Mol Psychiatry. 2018 Aug;23(8):1764-1772. doi: 10.1038/mp.2017.249. Epub 2018 Jan 9.

PMID:
29311665
16.

Allergists' opinions on anaphylaxis and epinephrine administration-a case-based survey.

Lieberman JA, Lieberman P, Wang J.

J Allergy Clin Immunol Pract. 2018 May - Jun;6(3):1075-1077.e1. doi: 10.1016/j.jaip.2017.11.031. Epub 2018 Jan 4. No abstract available.

PMID:
29306683
17.

Cost-effectiveness of HLA-DQB1/HLA-B pharmacogenetic-guided treatment and blood monitoring in US patients taking clozapine.

Girardin FR, Poncet A, Perrier A, Vernaz N, Pletscher M, F Samer C, Lieberman JA, Villard J.

Pharmacogenomics J. 2018 Jan 3. doi: 10.1038/s41397-017-0004-2. [Epub ahead of print]

PMID:
29298994
18.

Psychiatrists Diagnosing the President - Moral Imperative or Ethical Violation?

Lieberman JA.

N Engl J Med. 2018 Feb 1;378(5):483-484. doi: 10.1056/NEJMc1716751. Epub 2017 Dec 27. No abstract available.

19.

Nutrition education for cardiovascular disease prevention in individuals with spinal cord injuries: study protocol for a randomized controlled trial.

Lieberman JA, McClelland JW, Goff DC Jr, Racine E, Dulin MF, Bauman WA, Niemeier J, Hirsch MA, Norton HJ, Moore CG.

Trials. 2017 Dec 4;18(1):584. doi: 10.1186/s13063-017-2263-2.

20.

Utility of Imaging-Based Biomarkers for Glutamate-Targeted Drug Development in Psychotic Disorders: A Randomized Clinical Trial.

Javitt DC, Carter CS, Krystal JH, Kantrowitz JT, Girgis RR, Kegeles LS, Ragland JD, Maddock RJ, Lesh TA, Tanase C, Corlett PR, Rothman DL, Mason G, Qiu M, Robinson J, Potter WZ, Carlson M, Wall MM, Choo TH, Grinband J, Lieberman JA.

JAMA Psychiatry. 2018 Jan 1;75(1):11-19. doi: 10.1001/jamapsychiatry.2017.3572.

PMID:
29167877

Supplemental Content

Loading ...
Support Center